Multisystem inflammatory syndrome in children is a post-infectious presentation SARS-CoV-2 associated with expansion of the T cell receptor Vβ21.3+ T-cell subgroup. Here we apply muti-single cell omics to compare the inflammatory process in children with acute respiratory COVID-19 and those presenting with non SARS-CoV-2 infections in children. Here we show that in Multi-Inflammatory Syndrome in Children (MIS-C), the natural killer cell and monocyte population demonstrate heightened CD95 (Fas) and Interleuking 18 receptor expression. Additionally, TCR Vβ21.3+ CD4+ T-cells exhibit skewed differentiation towards T helper 1, 17 and regulatory T cells, with increased expression of the co-stimulation receptors ICOS, CD28 and interleukin 18 receptor. We observe no functional evidence for NLRP3 inflammasome pathway overactivation, though MIS-C monocytes show elevated active caspase 8. This, coupled with raised IL18 mRNA expression in CD16- NK cells on single cell RNA sequencing analysis, suggests interleukin 18 and CD95 signalling may trigger activation of TCR Vβ21.3+ T-cells in MIS-C, driven by increased IL-18 production from activated monocytes and CD16- Natural Killer cells.
Oncogenic transformation and Oct4, Sox2, Klf4 and c-Myc (OSKM)-mediated induction of pluripotency are two independent and incompatible cellular fates. While continuous expression of OSKM can convert normal somatic cells into teratogenic pluripotent cells, it remains speculative what is the impact of transient OSKM expression in cancer cells. Here, we find that OSKM expression limits the growth of transformed lung cells by inducing apoptosis and senescence. We identify Oct4 and Klf4 as the main individual reprogramming factors responsible for this effect. Mechanistically, the induction of cell cycle inhibitor p21 downstream of the reprogramming factors acts as mediator of cell death and senescence. Using a variety of in vivo systems, including allografts, orthotopic transplantation and KRAS-driven lung cancer mouse models, we demonstrate that transient reprogramming by OSKM expression in cancer cells impairs tumor growth and reduces tumor burden. Altogether, our results show that the induction of transient reprogramming in cancer cells is antitumorigenic opening novel potential therapeutic avenues in oncology.
Background: Lower respiratory tract infection (LRTI) is a leading cause of morbidity and mortality among children admitted to paediatric intensive care units (PICUs). Accurate diagnosis is complicated by the breadth the broad spectrum of pathogens involved and the overlap of symptoms with non-infectious respiratory problems, often leading to diagnostic delays. This study aimed to identify early diagnostic biomarkers and characterise microbial-host interactions in paediatric LRTI. Methods: We re-analysed a metagenomic next-generation sequencing (mNGS) dataset from 261 PICU patients with acute respiratory failure, combining microbial and host transcriptomic profiles using differential expression, network, and machine-learning approaches. Candidate biomarkers were validated in an independent prospective cohort of 100 critically ill children (RASCALS), with non-bronchoscopic bronchoalveolar lavage (mini-BAL), blood cytokine profiling, and pathogen detection. Findings: Respiratory syncytial virus (RSV) and Haemophilus influenzae were the most enriched pathogens in LRTI cases. Host transcriptomics revealed activation of cytokine and chemokine signalling pathways. A seven-gene panel (IRF7, FFAR3, GZMB, FABP4, FN1, CXCL5, BCAR1) achieved high diagnostic accuracy, comparable to a published 14-gene model. In RASCALS, RSV detection combined with mini-BAL IL-8 or blood IL-4:TRAIL ratio improved diagnostic accuracy (71%) and correlated with ventilator-free days. Plasma C-reactive protein (CRP) and IL-6 further discriminated bacterial from non-bacterial infections (AUC 0.81 and 0.74, respectively). Interpretation: Integrating host and microbial markers provides a feasible route to early, accurate diagnosis of paediatric LRTI. The identified 7-gene panel and cytokine markers could be translated into PCR- or ELISA-based bedside assays to support rapid clinical decision-making and antimicrobial stewardship in PICU.